{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:11:33Z","timestamp":1787022693626,"version":"build-2736575974"},"reference-count":142,"publisher":"Society for Neuroscience","issue":"10","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":184,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009017","name":"ALS Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009836","name":"Huntington Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009408","name":"Fondation Brain Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009408","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jneurosci.org"],"crossmark-restriction":true},"short-container-title":["J. Neurosci."],"accepted":{"date-parts":[[2026,1,29]]},"published-print":{"date-parts":[[2026,3,11]]},"abstract":"<jats:p>Amyotrophic lateral sclerosis (ALS) and Huntington disease (HD) are lethal neurodegenerative diseases affecting motor function. Though their etiology and pathology are distinct, recent evidence suggests commonalities between TAR DNA-binding protein (TDP-43), which is associated with 97% of ALS cases, and huntingtin (HTT), the causative protein of HD. ALS is a heterogeneous, lethal neurodegenerative disease characterized by the progressive loss of upper and lower motor neurons, as well as brainstem and spinal cord degeneration. The causes of ALS are complex, variable, and, in some cases, unknown, but most cases involve mislocalization of the protein TDP-43. In contrast, HD is a monogenic, autosomal dominant, lethal neurodegenerative disease caused by polyglutamine expansion in HTT protein and characterized by the progressive loss of neurons in the brain, particularly in the striatum, which results in motor, cognitive, and behavioral changes. Although HD is not typically associated with motor neuron loss, recent evidence suggests a link between HTT and TDP-43 within the context of both ALS and HD, as well as links to related neurodegenerative diseases, such as frontotemporal dementia (FTD) and spinocerebellar ataxia type 2 (SCA2). Herein, we discuss confirmed cases of concurrent ALS and HD and the overlap of underlying disease mechanisms that potentially contribute to the onset and progression of these two devastating neurodegenerative diseases, with a focus on commonalities between TDP-43 and HTT. We propose that elucidating these commonalities will aid in the identification of broad-spectrum disease risk factors and potential overlapping treatment targets.<\/jats:p>","DOI":"10.1523\/jneurosci.0263-25.2026","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:55:18Z","timestamp":1773251718000},"page":"e0263252026","update-policy":"https:\/\/doi.org\/10.1523\/jneurosci.crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["ALS and Huntington Disease: Unraveling the Connections between TDP-43 and Huntingtin"],"prefix":"10.1523","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2907-372X","authenticated-orcid":false,"given":"Cailyn M.","family":"Perry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2407-1597","authenticated-orcid":false,"given":"Dale D. O.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"393","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"2026031110551294000_46.10.e0263252026.1","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00042"},{"key":"2026031110551294000_46.10.e0263252026.2","doi-asserted-by":"crossref","first-page":"e70549","DOI":"10.1096\/fj.202401781R","article-title":"Reduced palmitoylation of SQSTM1\/p62 in Huntington disease is associated with impaired autophagy","volume":"39","author":"Abrar","year":"2025","journal-title":"FASEB J"},{"key":"2026031110551294000_46.10.e0263252026.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00062-0"},{"key":"2026031110551294000_46.10.e0263252026.4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/21678421.2014.964258","article-title":"The El Escorial criteria: strengths and weaknesses","volume":"16","author":"Agosta","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2026031110551294000_46.10.e0263252026.5","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.013193"},{"key":"2026031110551294000_46.10.e0263252026.6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3233\/JHD-240028","article-title":"Protective proteolysis in Huntington\u2019s disease: unraveling the role of post-translational myristoylation of huntingtin in autophagy","volume":"13","author":"Alshehabi","year":"2024","journal-title":"J Huntingtons Dis"},{"key":"2026031110551294000_46.10.e0263252026.7","doi-asserted-by":"crossref","first-page":"2547975","DOI":"10.1080\/27694127.2025.2547975","article-title":"Sequestering sequestosome 1 via S-acylation in autophagy, Huntington disease, and beyond","volume":"4","author":"Alshehabi","year":"2025","journal-title":"Autophagy Rep"},{"key":"2026031110551294000_46.10.e0263252026.8","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.str.2023.06.002","article-title":"Delineation of functional subdomains of Huntingtin protein and their interaction with HAP40","volume":"31","author":"Alteen","year":"2023","journal-title":"Structure"},{"key":"2026031110551294000_46.10.e0263252026.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2006.10.093"},{"key":"2026031110551294000_46.10.e0263252026.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2005.02.038"},{"key":"2026031110551294000_46.10.e0263252026.11","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.038950"},{"key":"2026031110551294000_46.10.e0263252026.12","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-0062-8"},{"key":"2026031110551294000_46.10.e0263252026.13","doi-asserted-by":"crossref","first-page":"102484","DOI":"10.1016\/j.pneurobio.2023.102484","article-title":"Loss of TDP-43 promotes somatic CAG repeat expansion in Huntington\u2019s disease knock-in mice","volume":"227","author":"Bai","year":"2023","journal-title":"Prog Neurobiol"},{"key":"2026031110551294000_46.10.e0263252026.14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"2026031110551294000_46.10.e0263252026.15","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4014"},{"key":"2026031110551294000_46.10.e0263252026.16","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3390\/diagnostics11061051","article-title":"The effect of CAG repeats within the non-pathological range in the HTT gene on cognitive functions in patients with subjective cognitive decline and mild cognitive impairment","volume":"11","author":"Bessi","year":"2021","journal-title":"Diagnostics"},{"key":"2026031110551294000_46.10.e0263252026.17","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12455-5"},{"key":"2026031110551294000_46.10.e0263252026.18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s41983-024-00800-4","article-title":"Bulbar-onset amyotrophic lateral sclerosis in a patient with genetically confirmed Huntington\u2019s disease: a case study","volume":"60","author":"Bozovic","year":"2024","journal-title":"Egypt J Neurol Psychiatr Neurosurg"},{"key":"2026031110551294000_46.10.e0263252026.19","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adn4600"},{"key":"2026031110551294000_46.10.e0263252026.20","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2018.1439923"},{"key":"2026031110551294000_46.10.e0263252026.21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/cge.14472","article-title":"A mother and her daughter carrying a pathogenic expansion of the HTT gene with a phenotype encompassing motor neuron disease and Huntington\u2019s disease","volume":"105","author":"Canosa","year":"2024","journal-title":"Clin Genet"},{"key":"2026031110551294000_46.10.e0263252026.22","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-019-0248-4"},{"key":"2026031110551294000_46.10.e0263252026.23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neurobiolaging.2023.09.017","article-title":"Identifying risk loci for FTD and shared genetic component with ALS: a large-scale multitrait association analysis","volume":"134","author":"Chen","year":"2024","journal-title":"Neurobiol Aging"},{"key":"2026031110551294000_46.10.e0263252026.24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41419-024-06716-4","article-title":"HAP40 modulates mutant huntingtin aggregation and toxicity in Huntington\u2019s disease mice","volume":"15","author":"Chen","year":"2024","journal-title":"Cell Death Dis"},{"key":"2026031110551294000_46.10.e0263252026.25","doi-asserted-by":"publisher","DOI":"10.2478\/jtim-2023-0142"},{"key":"2026031110551294000_46.10.e0263252026.26","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-017-0047-3"},{"key":"2026031110551294000_46.10.e0263252026.27","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-019-03059-8"},{"key":"2026031110551294000_46.10.e0263252026.28","doi-asserted-by":"publisher","DOI":"10.3233\/JHD-150177"},{"key":"2026031110551294000_46.10.e0263252026.29","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkp342"},{"key":"2026031110551294000_46.10.e0263252026.30","first-page":"100130","article-title":"A probable cis-acting genetic modifier of Huntington disease frequent in individuals with African ancestry","volume":"3","author":"Dawson","year":"2022","journal-title":"HGG Adv"},{"key":"2026031110551294000_46.10.e0263252026.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2020.11.005"},{"key":"2026031110551294000_46.10.e0263252026.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2012.02.032"},{"key":"2026031110551294000_46.10.e0263252026.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2008.09.014"},{"key":"2026031110551294000_46.10.e0263252026.34","doi-asserted-by":"publisher","DOI":"10.1177\/1073858410390378"},{"key":"2026031110551294000_46.10.e0263252026.35","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201490808"},{"key":"2026031110551294000_46.10.e0263252026.36","doi-asserted-by":"publisher","DOI":"10.1038\/nature09320"},{"key":"2026031110551294000_46.10.e0263252026.37","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/WCO.0000000000001413","article-title":"Antisense oligonucleotide therapy in amyotrophic lateral sclerosis","volume":"38","author":"Erdi-Krausz","year":"2025","journal-title":"Curr Opin Neurol"},{"key":"2026031110551294000_46.10.e0263252026.38","doi-asserted-by":"publisher","DOI":"10.3233\/jhd-239001"},{"key":"2026031110551294000_46.10.e0263252026.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2018.07.005"},{"key":"2026031110551294000_46.10.e0263252026.40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/17582024.2024.2402216","article-title":"Tofersen for SOD1 ALS","volume":"14","author":"Everett","year":"2024","journal-title":"Neurodegener Dis Manag"},{"key":"2026031110551294000_46.10.e0263252026.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104835"},{"key":"2026031110551294000_46.10.e0263252026.42","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1125433"},{"key":"2026031110551294000_46.10.e0263252026.43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s40478-025-02084-y","article-title":"TDP-43 pathology is associated with divergent protein profiles in ALS brain and spinal cord","volume":"13","author":"Feneberg","year":"2025","journal-title":"Acta Neuropathol Commun"},{"key":"2026031110551294000_46.10.e0263252026.44","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fnmol.2019.00301","article-title":"Structural insights into TDP-43 and effects of post-translational modifications","volume":"12","author":"Fran\u00e7ois-Moutal","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"2026031110551294000_46.10.e0263252026.45","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.125039"},{"key":"2026031110551294000_46.10.e0263252026.46","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/s41588-025-02191-5","article-title":"Genetic modifiers of somatic expansion and clinical phenotypes in Huntington\u2019s disease highlight shared and tissue-specific effects","volume":"57","author":"Genetic Modifiers of Huntington\u2019s Disease (GeM-HD) Consortium","year":"2025","journal-title":"Nat Genet"},{"key":"2026031110551294000_46.10.e0263252026.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.04.026"},{"key":"2026031110551294000_46.10.e0263252026.48","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09363-4"},{"key":"2026031110551294000_46.10.e0263252026.49","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cels.2022.01.005","article-title":"Dynamics of huntingtin protein interactions in the striatum identifies candidate modifiers of Huntington disease","volume":"13","author":"Greco","year":"2022","journal-title":"Cell Syst"},{"key":"2026031110551294000_46.10.e0263252026.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2017.03.023"},{"key":"2026031110551294000_46.10.e0263252026.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2009.11.020"},{"key":"2026031110551294000_46.10.e0263252026.52","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41594-018-0064-2","article-title":"Atomic structures of TDP-43 LCD segments and insights into reversible or pathogenic aggregation","volume":"25","author":"Guenther","year":"2018","journal-title":"Nat Struct Mol Biol"},{"key":"2026031110551294000_46.10.e0263252026.53","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(03)00594-4"},{"key":"2026031110551294000_46.10.e0263252026.54","doi-asserted-by":"publisher","DOI":"10.1038\/nature25502"},{"key":"2026031110551294000_46.10.e0263252026.55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-021-02895-4","article-title":"Huntingtin structure is orchestrated by HAP40 and shows a polyglutamine expansion-specific interaction with exon 1","volume":"4","author":"Harding","year":"2021","journal-title":"Commun Biol"},{"key":"2026031110551294000_46.10.e0263252026.56","doi-asserted-by":"crossref","first-page":"96","DOI":"10.14336\/AD.2023.0519","article-title":"The inflammatory puzzle: piecing together the links between neuroinflammation and amyotrophic lateral sclerosis","volume":"15","author":"He","year":"2024","journal-title":"Aging Dis"},{"key":"2026031110551294000_46.10.e0263252026.57","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000061"},{"key":"2026031110551294000_46.10.e0263252026.58","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00401-021-02385-1","article-title":"Amyotrophic lateral sclerosis is over-represented in two Huntington\u2019s disease brain bank cohorts: further evidence to support genetic pleiotropy of pathogenic HTT gene expansion","volume":"143","author":"Hickman","year":"2022","journal-title":"Acta Neuropathol"},{"key":"2026031110551294000_46.10.e0263252026.59","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/cpt.3341","article-title":"Advances in clinical therapies for Huntington\u2019s disease and the promise of multi-targeted\/functional drugs based on clinicaltrials.gov","volume":"116","author":"Huang","year":"2024","journal-title":"Clin Pharmacol Ther"},{"key":"2026031110551294000_46.10.e0263252026.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2004.11.027"},{"key":"2026031110551294000_46.10.e0263252026.61","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddr242"},{"key":"2026031110551294000_46.10.e0263252026.62","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-075037"},{"key":"2026031110551294000_46.10.e0263252026.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2024.102399"},{"key":"2026031110551294000_46.10.e0263252026.64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ydbio.2014.04.005"},{"key":"2026031110551294000_46.10.e0263252026.65","doi-asserted-by":"publisher","DOI":"10.3233\/JHD-200438"},{"key":"2026031110551294000_46.10.e0263252026.66","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-020-00513-7"},{"key":"2026031110551294000_46.10.e0263252026.67","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002858"},{"key":"2026031110551294000_46.10.e0263252026.68","doi-asserted-by":"crossref","first-page":"418765","DOI":"10.1155\/2008\/418765","article-title":"Peroxisome proliferator-activated receptor-gamma in amyotrophic lateral sclerosis and Huntington\u2019s disease","volume":"2008","author":"Kiaei","year":"2008","journal-title":"PPAR Res"},{"key":"2026031110551294000_46.10.e0263252026.69","doi-asserted-by":"crossref","first-page":"e154108","DOI":"10.1172\/jci.insight.154108","article-title":"A pathogenic proteolysis\u2013resistant huntingtin isoform induced by an antisense oligonucleotide maintains huntingtin function","volume":"7","author":"Kim","year":"2022","journal-title":"JCI Insight"},{"key":"2026031110551294000_46.10.e0263252026.70","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199405193302001"},{"key":"2026031110551294000_46.10.e0263252026.71","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu522"},{"key":"2026031110551294000_46.10.e0263252026.72","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.07.003"},{"key":"2026031110551294000_46.10.e0263252026.73","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.06.036"},{"key":"2026031110551294000_46.10.e0263252026.74","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2022.03.004"},{"key":"2026031110551294000_46.10.e0263252026.75","doi-asserted-by":"crossref","first-page":"105479","DOI":"10.1016\/j.nbd.2021.105479","article-title":"Rescue of aberrant huntingtin palmitoylation ameliorates mutant huntingtin-induced toxicity","volume":"158","author":"Lemari\u00e9","year":"2021","journal-title":"Neurobiol Dis"},{"key":"2026031110551294000_46.10.e0263252026.76","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7183"},{"key":"2026031110551294000_46.10.e0263252026.77","doi-asserted-by":"publisher","DOI":"10.1101\/2020.12.14.422689"},{"key":"2026031110551294000_46.10.e0263252026.78","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M511007200"},{"key":"2026031110551294000_46.10.e0263252026.79","doi-asserted-by":"publisher","DOI":"10.1007\/s10863-017-9727-7"},{"key":"2026031110551294000_46.10.e0263252026.80","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.05.077"},{"key":"2026031110551294000_46.10.e0263252026.81","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(97)00238-4"},{"key":"2026031110551294000_46.10.e0263252026.82","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-023-00845-8"},{"key":"2026031110551294000_46.10.e0263252026.83","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"2026031110551294000_46.10.e0263252026.84","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-011-0845-8"},{"key":"2026031110551294000_46.10.e0263252026.85","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70195-2"},{"key":"2026031110551294000_46.10.e0263252026.86","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1042\/BST20231290","article-title":"Let\u2019s get fat: emergence of S -acylation as a therapeutic target in Huntington disease","volume":"52","author":"Martin","year":"2024","journal-title":"Biochem Soc Trans"},{"key":"2026031110551294000_46.10.e0263252026.87","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14393"},{"key":"2026031110551294000_46.10.e0263252026.88","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2022.12.019"},{"key":"2026031110551294000_46.10.e0263252026.89","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-024-00700-8"},{"key":"2026031110551294000_46.10.e0263252026.90","first-page":"S65","article-title":"Frontotemporal dementia: an updated overview","volume":"51","author":"Mohandas","year":"2009","journal-title":"Indian J Psychiatry"},{"key":"2026031110551294000_46.10.e0263252026.91","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M117.775965"},{"key":"2026031110551294000_46.10.e0263252026.92","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30161-8"},{"key":"2026031110551294000_46.10.e0263252026.93","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90542-1"},{"key":"2026031110551294000_46.10.e0263252026.94","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1221292110"},{"key":"2026031110551294000_46.10.e0263252026.95","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41593-024-01850-w","article-title":"Aberrant splicing in Huntington\u2019s disease accompanies disrupted TDP-43 activity and altered m6A RNA modification","volume":"28","author":"Nguyen","year":"2025","journal-title":"Nat Neurosci"},{"key":"2026031110551294000_46.10.e0263252026.96","doi-asserted-by":"crossref","first-page":"fcae087","DOI":"10.1093\/braincomms\/fcae087","article-title":"Repeat expansions in AR, ATXN1, ATXN2 and HTT in Norwegian patients diagnosed with amyotrophic lateral sclerosis","volume":"6","author":"Novy","year":"2024","journal-title":"Brain Commun"},{"key":"2026031110551294000_46.10.e0263252026.97","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1420103111"},{"key":"2026031110551294000_46.10.e0263252026.98","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2023.05.006"},{"key":"2026031110551294000_46.10.e0263252026.99","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-006-0267-z"},{"key":"2026031110551294000_46.10.e0263252026.100","doi-asserted-by":"crossref","unstructured":"Parsons MP , Raymond LA (2023) Huntington disease. In: Neurobiology of brain disorders, Ed 2. ( Zigmond MJ , Wiley CA , Chesselet M-F , eds), pp 275\u2013292. Academic Press.","DOI":"10.1016\/B978-0-323-85654-6.00042-3"},{"key":"2026031110551294000_46.10.e0263252026.101","doi-asserted-by":"publisher","DOI":"10.3109\/17482960903055958"},{"key":"2026031110551294000_46.10.e0263252026.102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003930"},{"key":"2026031110551294000_46.10.e0263252026.103","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43872-1"},{"key":"2026031110551294000_46.10.e0263252026.104","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2014.07.021"},{"key":"2026031110551294000_46.10.e0263252026.105","doi-asserted-by":"publisher","DOI":"10.1007\/s004010050539"},{"key":"2026031110551294000_46.10.e0263252026.106","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2015.1039219"},{"key":"2026031110551294000_46.10.e0263252026.107","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jamaneurol.2019.2044","article-title":"Lifetime risk and heritability of amyotrophic lateral sclerosis","volume":"76","author":"Ryan","year":"2019","journal-title":"JAMA Neurol"},{"key":"2026031110551294000_46.10.e0263252026.108","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.76"},{"key":"2026031110551294000_46.10.e0263252026.109","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.106049"},{"key":"2026031110551294000_46.10.e0263252026.110","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140723"},{"key":"2026031110551294000_46.10.e0263252026.111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004405"},{"key":"2026031110551294000_46.10.e0263252026.112","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-015-0223-4"},{"key":"2026031110551294000_46.10.e0263252026.113","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M513507200"},{"key":"2026031110551294000_46.10.e0263252026.114","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0b013e31818e8951"},{"key":"2026031110551294000_46.10.e0263252026.115","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2013-101796"},{"key":"2026031110551294000_46.10.e0263252026.116","doi-asserted-by":"publisher","DOI":"10.5483\/BMBRep.2020.53.1.283"},{"key":"2026031110551294000_46.10.e0263252026.117","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2016.11.010"},{"key":"2026031110551294000_46.10.e0263252026.118","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2016.1267768"},{"key":"2026031110551294000_46.10.e0263252026.119","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-020-00397-1"},{"key":"2026031110551294000_46.10.e0263252026.120","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1038\/s41586-023-06994-6","article-title":"Publisher correction: m1A in CAG repeat RNA binds to TDP-43 and induces neurodegeneration","volume":"625","author":"Sun","year":"2024","journal-title":"Nature"},{"key":"2026031110551294000_46.10.e0263252026.121","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddp242"},{"key":"2026031110551294000_46.10.e0263252026.122","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-012-1005-5"},{"key":"2026031110551294000_46.10.e0263252026.123","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2169\/internalmedicine.3232-23","article-title":"Concurrent amyotrophic lateral sclerosis and Huntington\u2019s disease: a case report","volume":"64","author":"Takahashi","year":"2024","journal-title":"Intern Med"},{"key":"2026031110551294000_46.10.e0263252026.124","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-3-15"},{"key":"2026031110551294000_46.10.e0263252026.125","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s10787-024-01477-0","article-title":"Neuroinflammation and the role of epigenetic-based therapies for Huntington\u2019s disease management: the new paradigm","volume":"32","author":"Temgire","year":"2024","journal-title":"Inflammopharmacology"},{"key":"2026031110551294000_46.10.e0263252026.126","doi-asserted-by":"publisher","DOI":"10.1080\/14660820410021311"},{"key":"2026031110551294000_46.10.e0263252026.127","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-013-1090-0"},{"key":"2026031110551294000_46.10.e0263252026.128","doi-asserted-by":"publisher","DOI":"10.1038\/nn.2778"},{"key":"2026031110551294000_46.10.e0263252026.129","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.31.5.377"},{"key":"2026031110551294000_46.10.e0263252026.130","doi-asserted-by":"crossref","first-page":"103450","DOI":"10.1016\/j.nicl.2023.103450","article-title":"Study protocol of IMAGINE-HD: imaging iron accumulation and neuroinflammation with 7T-MRI + CSF in Huntington\u2019s disease","volume":"39","author":"Van De Zande","year":"2023","journal-title":"Neuroimage Clin"},{"key":"2026031110551294000_46.10.e0263252026.131","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3622"},{"key":"2026031110551294000_46.10.e0263252026.132","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd5393"},{"key":"2026031110551294000_46.10.e0263252026.133","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2020.04.001"},{"key":"2026031110551294000_46.10.e0263252026.134","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201797452"},{"key":"2026031110551294000_46.10.e0263252026.135","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1170996"},{"key":"2026031110551294000_46.10.e0263252026.136","doi-asserted-by":"publisher","DOI":"10.1042\/ebc20200010"},{"key":"2026031110551294000_46.10.e0263252026.137","doi-asserted-by":"publisher","DOI":"10.1172\/JCI130988"},{"key":"2026031110551294000_46.10.e0263252026.138","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1225-24.2024"},{"key":"2026031110551294000_46.10.e0263252026.139","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2019.04.007"},{"key":"2026031110551294000_46.10.e0263252026.140","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ado5264"},{"key":"2026031110551294000_46.10.e0263252026.141","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1080\/15548627.2019.1643185","article-title":"SQSTM1\/p62 promotes mitochondrial ubiquitination independently of PINK1 and PRKN\/parkin in mitophagy","volume":"15","author":"Yamada","year":"2019","journal-title":"Autophagy"},{"key":"2026031110551294000_46.10.e0263252026.142","doi-asserted-by":"publisher","DOI":"10.4103\/2152-7806.169561"}],"container-title":["The Journal of Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1523\/JNEUROSCI.0263-25.2026","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1523\/JNEUROSCI.0263-25.2026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:55:38Z","timestamp":1773251738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jneurosci.org\/lookup\/doi\/10.1523\/JNEUROSCI.0263-25.2026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":142,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,3,11]]},"published-print":{"date-parts":[[2026,3,11]]}},"alternative-id":["10.1523\/JNEUROSCI.0263-25.2026"],"URL":"https:\/\/doi.org\/10.1523\/jneurosci.0263-25.2026","relation":{},"ISSN":["0270-6474","1529-2401"],"issn-type":[{"value":"0270-6474","type":"print"},{"value":"1529-2401","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]}}}